Breast Cancer

SWOG S1416
NCI Sponsored
Phase II Randomized Placebo-controlled Trial of Cisplatin with or without ABT-888 (Veliparib) inMetastatic Triple Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer.
View on ClinicalTrials.gov
NRG-BR003
NCI
Sponsored
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
View on ClinicalTrials.gov
SPI-GCF-301
Industry
Sponsored
Randomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) (ADVANCE)
View on ClinicalTrials.gov

Advanced Colon Cancer

E7208
NCI
Sponsored
A Randomized Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic Antibody, Ramucirumab, in Advanced, K-ras Wild-type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy
View on ClinicalTrials.gov

Prostate Cancer

CK – 001
Industry
Sponsored
Virtual HDR CyberKnife Radiosurgery for Locally Recurrent Prostatic Carcinoma: a Phase II Study
View on ClinicalTrials.gov
RTOG 0924
NCI
Sponsored
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
View on ClinicalTrials.gov
PROGRESS
NIH Sponsored
Prostate Cancer Online Guide & Resources for Electronic Survivorship Service
For information about cancer clinical trials at AtlantiCare, please call the Oncology Clinical Research Coordinator, Kathryn A. Thomas, RN, BSN, OCN, CCRP at 609-677-7735.